08 Sep
|
Puzzle Medical Devices
|
Montreal
08 Sep
Puzzle Medical Devices
Montreal
Puzzle Medical Devices® Inc. is developing a percutaneous heart pump for patients with advanced heart failure. The device’s design allows for protected percutaneous implantation to support both renal and cardiac function through a 4 mm-pump implanted in the descending aorta with a 4 Fr axillary driveline, allowing full patient mobility. To date, Puzzle Medical Devices® Inc. has successfully:
- Completed 3 financing rounds in 2022, 2023, and 2025;
- Completed its first-in-human study with all patients experiencing improvements in cardiac and kidney function from 2022 - 2024;
- Grew its team to ~50 people;
Received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation in 2021.
Here is the link to submit a spontaneous application.
📌 Spontaneous application (Finance) (Montreal)
🏢 Puzzle Medical Devices
📍 Montreal